We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$3.25B
Cap. Flow
+$3.84B
Cap. Flow %
24.9%
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$246M
2
MSFT icon
Microsoft
MSFT
+$216M
3
AMZN icon
Amazon
AMZN
+$130M
4
TSLA icon
Tesla
TSLA
+$79.6M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$73.3M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 12.21%
3 Financials 12.1%
4 Consumer Discretionary 11.41%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDYN icon
2051
Grid Dynamics Holdings
GDYN
$644M
$325K ﹤0.01%
23,054
+8,370
+57% +$171K
KDNY
2052
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$325K ﹤0.01%
19,839
+7,322
+58% +$99.6K
TBPH icon
2053
Theravance Biopharma
TBPH
$878M
$324K ﹤0.01%
33,942
+12,090
+55% +$118K
UBA
2054
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$324K ﹤0.01%
17,230
+6,005
+53% +$118K
PGC icon
2055
Peapack-Gladstone Financial
PGC
$822M
$323K ﹤0.01%
9,287
+3,215
+53% +$118K
GSBC icon
2056
Great Southern Bancorp
GSBC
$888M
$323K ﹤0.01%
5,468
+2,063
+61% +$124K
ECVT icon
2057
Ecovyst
ECVT
$1.1B
$322K ﹤0.01%
27,874
+9,939
+55% +$104K
ARQT icon
2058
Arcutis Biotherapeutics
ARQT
$3.25B
$322K ﹤0.01%
16,718
+6,170
+58% +$104K
TBRG
2059
DELISTED
TruBridge
TBRG
$322K ﹤0.01%
9,346
+3,490
+60% +$107K
RYZ
2060
Ryerson Holding Corp
RYZ
$1.5B
$322K ﹤0.01%
9,181
+3,333
+57% +$90.7K
FSP
2061
Franklin Street Properties
FSP
$46.4M
$321K ﹤0.01%
54,424
+30,675
+129% +$177K
ERAS icon
2062
Erasca
ERAS
$6.25B
$321K ﹤0.01%
37,277
+28,917
+346% +$335K
TR icon
2063
Tootsie Roll Industries
TR
$3.02B
$319K ﹤0.01%
10,280
+3,072
+43% +$91.7K
BFS
2064
Saul Centers
BFS
$865M
$318K ﹤0.01%
6,040
+2,156
+56% +$106K
IONS icon
2065
Ionis Pharmaceuticals
IONS
$9.28B
$318K ﹤0.01%
+8,579
New +$281K
DNMR
2066
DELISTED
Danimer Scientific, Inc.
DNMR
$316K ﹤0.01%
1,350
+482
+56% +$97.3K
CASS icon
2067
Cass Information Systems
CASS
$750M
$315K ﹤0.01%
8,536
+2,833
+50% +$113K
MSBI icon
2068
Midland States Bancorp
MSBI
$698M
$314K ﹤0.01%
10,894
+4,049
+59% +$116K
SPNT icon
2069
SiriusPoint
SPNT
$2.7B
$314K ﹤0.01%
42,002
+20,315
+94% +$161K
PNTG icon
2070
Pennant Group
PNTG
$1.35B
$314K ﹤0.01%
16,829
+5,469
+48% +$91.3K
VSEC icon
2071
VSE Corp
VSEC
$6.48B
$313K ﹤0.01%
6,791
+2,386
+54% +$119K
GRBK icon
2072
Green Brick Partners
GRBK
$3.04B
$312K ﹤0.01%
15,773
+5,757
+57% +$133K
HSTM icon
2073
HealthStream
HSTM
$849M
$309K ﹤0.01%
15,509
+6,429
+71% +$145K
SITE icon
2074
SiteOne Landscape Supply
SITE
$4.27B
$309K ﹤0.01%
+1,908
New +$347K
IIIV icon
2075
i3 Verticals
IIIV
$325M
$308K ﹤0.01%
11,069
+3,987
+56% +$98.3K

Similar funds

MetLife Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.

  • MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
  • MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
  • MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
  • MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
  • MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
  • MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.